US Patent Issued to Naegis Pharmaceuticals on July 21 for "Leukotriene synthesis inhibitors" (Canadian Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,668, issued on July 21, was assigned to Naegis Pharmaceuticals Inc. (Vancouver, Canada).

"Leukotriene synthesis inhibitors" was invented by David L. Burgoyne (Delta, Canada), Erin DeBruin (Port Coquitlam, Canada), Julia Fonarev (Richmond, Canada), James Gee Ken Yee (Port Moody, Canada) and John Michael Langlands (Richmond, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions."

The patent was filed ...